Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

Agree that B, at this point, is best bet for success. I did read the other ED doc review that you mentioned and of course he has good things to say about the gm positive and potential gm negative drugs with the caveat being as always, will they work without major side effects? Will the poster show new relevant data with gm negatives in Denmark? or rehash old data? So far from real use for gm - drugs. But yes, B looks good.

helpful thread about mucositis- data for B-OM looks better: but how long to wait for real value added to CTIX?

I agree with you that K is risky at this juncture and that your cautiously optimistic stance is the only one that makes any sense. Wouldn't it be nice to have more data about recent cohorts?

As I am sure you have been told many times your posts are worthwhile